This move is archived. Current quotes and coverage live on the stock page.
Get MDNA alerts:
Medicenna Therapeutics Corp is seeing a positive uptick in its stock price, reflecting investor optimism.
In the latest trading session, Medicenna Therapeutics Corp (MDNA.TO) experienced a notable increase of 1.22%, closing at CA$0.41. This rise comes amid strategic developments and market positioning that may be influencing investor sentiment.
Investor takeaway: While Medicenna's stock is gaining, investors should remain cautious and consider the broader market dynamics and company fundamentals.
Advertisement
Medicenna Therapeutics Corp
MDNA.TO
MDNA.TO
Medicenna Therapeutics Corp
WealthAwesomeMarket cap
$43.38M
52W high
$1.97
52W low
$0.34
1W change
+0.00%
Beta
1.96
Analyst Price Targets
Based on analyst covering MDNA
Wall Street analysts forecast MDNA stock price to rise 580.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.20
+580.9% Upside
Current Price
C$0.47
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDNA's historical volatility
30-Day Vol
61.4%
Annualized
90-Day Vol
65.1%
Annualized
Trend (90d)
+47.2%
Annualized drift
90d Mean
C$0.56
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.50 | C$0.40 – C$0.61 |
| 60 trading days | C$0.53 | C$0.39 – C$0.71 |
| 90 trading days | C$0.56 | C$0.39 – C$0.80 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Medicenna's Market Cap Reaches CA$34.6 Million
With a market cap of CA$34.6 million, Medicenna remains a small-cap player in the biotech sector, which can lead to higher volatility and risk.
Bull case
Medicenna recently raised about $4.44 million through a public offering. This capital could support future growth and development, potentially boosting investor confidence.
Bear case
Despite the positive movement, Medicenna's lack of revenue and negative earnings per share could pose risks for investors. It's essential to keep an eye on the company's financial health.
Advertisement
Recent Developments Fuel Investor Confidence
Medicenna recently finalized the terms for a public offering, pricing units at CA$0.50 each. This move is seen as a strategic effort to strengthen its financial position, which could be a key factor in the stock's recent performance.
Market Sentiment and Future Outlook
The increase in Medicenna's stock price reflects a broader market sentiment favoring biotech companies with potential growth opportunities. Investors should keep an eye on upcoming financial reports and developments that may impact the company's trajectory.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
